Twist Bioscience (TWST) Competitors $33.68 +0.11 (+0.33%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$33.98 +0.30 (+0.89%) As of 08/1/2025 06:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock TWST vs. ADPT, BEAM, CRSP, TXG, VCYT, BPMC, ROIV, LEGN, RGC, and ELANShould you be buying Twist Bioscience stock or one of its competitors? The main competitors of Twist Bioscience include Adaptive Biotechnologies (ADPT), Beam Therapeutics (BEAM), CRISPR Therapeutics (CRSP), 10x Genomics (TXG), Veracyte (VCYT), Blueprint Medicines (BPMC), Roivant Sciences (ROIV), Legend Biotech (LEGN), Regencell Bioscience (RGC), and Elanco Animal Health (ELAN). Twist Bioscience vs. Its Competitors Adaptive Biotechnologies Beam Therapeutics CRISPR Therapeutics 10x Genomics Veracyte Blueprint Medicines Roivant Sciences Legend Biotech Regencell Bioscience Elanco Animal Health Twist Bioscience (NASDAQ:TWST) and Adaptive Biotechnologies (NASDAQ:ADPT) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, valuation, dividends, institutional ownership, risk, earnings, analyst recommendations and media sentiment. Is TWST or ADPT more profitable? Twist Bioscience has a net margin of -54.98% compared to Adaptive Biotechnologies' net margin of -74.84%. Twist Bioscience's return on equity of -33.48% beat Adaptive Biotechnologies' return on equity.Company Net Margins Return on Equity Return on Assets Twist Bioscience-54.98% -33.48% -25.34% Adaptive Biotechnologies -74.84%-62.79%-24.55% Do analysts recommend TWST or ADPT? Twist Bioscience presently has a consensus price target of $50.40, indicating a potential upside of 49.64%. Adaptive Biotechnologies has a consensus price target of $11.33, indicating a potential upside of 9.71%. Given Twist Bioscience's higher probable upside, equities analysts clearly believe Twist Bioscience is more favorable than Adaptive Biotechnologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Twist Bioscience 1 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.70Adaptive Biotechnologies 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.83 Which has preferable valuation & earnings, TWST or ADPT? Adaptive Biotechnologies has lower revenue, but higher earnings than Twist Bioscience. Adaptive Biotechnologies is trading at a lower price-to-earnings ratio than Twist Bioscience, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTwist Bioscience$312.97M6.45-$208.73M-$3.25-10.36Adaptive Biotechnologies$178.96M8.77-$159.49M-$0.96-10.76 Does the media prefer TWST or ADPT? In the previous week, Twist Bioscience had 9 more articles in the media than Adaptive Biotechnologies. MarketBeat recorded 12 mentions for Twist Bioscience and 3 mentions for Adaptive Biotechnologies. Adaptive Biotechnologies' average media sentiment score of 1.11 beat Twist Bioscience's score of 0.86 indicating that Adaptive Biotechnologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Twist Bioscience 5 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Adaptive Biotechnologies 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals and insiders believe in TWST or ADPT? 99.2% of Adaptive Biotechnologies shares are held by institutional investors. 3.0% of Twist Bioscience shares are held by insiders. Comparatively, 6.4% of Adaptive Biotechnologies shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Which has more volatility & risk, TWST or ADPT? Twist Bioscience has a beta of 2.37, meaning that its share price is 137% more volatile than the S&P 500. Comparatively, Adaptive Biotechnologies has a beta of 1.92, meaning that its share price is 92% more volatile than the S&P 500. SummaryTwist Bioscience and Adaptive Biotechnologies tied by winning 8 of the 16 factors compared between the two stocks. Get Twist Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for TWST and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TWST and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TWST vs. The Competition Export to ExcelMetricTwist BioscienceMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.01B$3.00B$5.49B$9.54BDividend YieldN/A2.43%4.73%4.09%P/E Ratio-10.3617.7428.8323.83Price / Sales6.45179.21372.0766.02Price / CashN/A41.9535.4557.96Price / Book4.178.508.275.54Net Income-$208.73M-$55.06M$3.25B$259.28M7 Day Performance-6.42%-3.99%-3.73%-4.68%1 Month Performance-10.62%9.58%4.29%4.36%1 Year Performance-21.62%6.70%25.87%17.88% Twist Bioscience Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TWSTTwist Bioscience3.5578 of 5 stars$33.68+0.3%$50.40+49.6%-36.5%$2.01B$312.97M-10.36990News CoverageUpcoming EarningsShort Interest ↑Gap DownADPTAdaptive Biotechnologies3.022 of 5 stars$10.61-1.3%$10.57-0.4%+132.1%$1.61B$189.53M-11.05790Positive NewsUpcoming EarningsGap DownBEAMBeam Therapeutics2.6099 of 5 stars$20.83-4.1%$48.75+134.0%-37.9%$2.09B$63.52M-4.52510Upcoming EarningsInsider TradeGap DownCRSPCRISPR Therapeutics2.8206 of 5 stars$63.75-1.6%$71.31+11.9%+2.3%$5.51B$35M-14.10460Upcoming EarningsAnalyst RevisionGap DownTXG10x Genomics3.7695 of 5 stars$14.64+3.8%$13.23-9.6%-33.5%$1.80B$610.78M-11.261,240News CoverageUpcoming EarningsAnalyst ForecastShort Interest ↑Gap DownVCYTVeracyte2.9116 of 5 stars$25.02-0.9%$40.90+63.5%+3.0%$1.96B$463.39M61.03790Positive NewsUpcoming EarningsHigh Trading VolumeBPMCBlueprint Medicines0.7266 of 5 stars$129.46flat$128.25-0.9%N/A$8.36B$562.12M-52.41640Upcoming EarningsROIVRoivant Sciences2.072 of 5 stars$11.35-1.7%$16.50+45.4%+6.5%$7.72B$29.05M-45.40860Positive NewsUpcoming EarningsLEGNLegend Biotech3.5653 of 5 stars$41.51-4.3%$73.33+76.7%-29.5%$7.63B$627.24M-70.352,609Positive NewsRGCRegencell Bioscience0.0502 of 5 stars$13.80-8.3%N/AN/A$7.44BN/A0.0010Positive NewsELANElanco Animal Health3.8177 of 5 stars$14.59-2.2%$16.17+10.8%+5.9%$7.25B$4.44B19.729,000Positive NewsUpcoming Earnings Related Companies and Tools Related Companies Adaptive Biotechnologies Alternatives Beam Therapeutics Alternatives CRISPR Therapeutics Alternatives 10x Genomics Alternatives Veracyte Alternatives Blueprint Medicines Alternatives Roivant Sciences Alternatives Legend Biotech Alternatives Regencell Bioscience Alternatives Elanco Animal Health Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TWST) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredToo busy to trade? Good.Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...Timothy Sykes | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Twist Bioscience Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Twist Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
